Search research articles
Contact Us
Filters
Showing results (1-10 of 18) with videos related to
Page
of 2
Sort By:
Journal of Drugs in Dermatology : JDD
|
November 7, 2022
#Laser Surgery: How Lasers are Portrayed on Instagram
Jessica Labadie, Supriya Immaneni, Jeffrey Dover
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
January 5, 2022
Surgical Dermatology and Private Equity: A Review of the Literature and Discussion
Alexander L Fogel, Sara Hogan, Jeffrey Dover
Skin Therapy Letter
|
July 13, 2023
DaxibotulinumtoxinA-lanm (Daxxify™): A Comprehensive Overview
Nicole Salame, Ariel E Eber, Jeffrey Dover
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
July 8, 2026
Clinical Risk and Regulatory Oversight for Office-Based Cosmetic Procedures: A State-By-State Analysis
Sara Hogan, Micah Brown, Jamon Thomas, et al.
Journal of the American Academy of Dermatology
|
October 27, 2012
Evaluating facial pores and skin texture after low-energy nonablative fractional 1440-nm laser treatments
Nazanin Saedi, Kathleen Petrell, Kenneth Arndt, et al.
Journal of Cosmetic Dermatology
|
September 18, 2021
The impact of COVD-19 on North American dermatology practices
Misha Zarbafian, Danny Guo, Jeffrey Dover, et al.
Aesthetic Surgery Journal
|
December 1, 2009
An analysis of safety data from five phase III clinical trials on the use of botulinum neurotoxin type A-ABO for the treatment of glabellar lines
Mark Rubin, Jeffrey Dover, Corey Maas, et al.
Archives of Dermatology
|
April 21, 2010
Blinded, randomized, quantitative grading comparison of minimally invasive, fractional radiofrequency and surgical face-lift to treat skin laxity
Macrene Alexiades-Armenakas, David Rosenberg, Bradley Renton, et al.
Clinics in Dermatology
|
January 4, 2020
The malleability of beauty: perceptual adaptation
Mayra B C Maymone, Melissa Laughter, Jeffrey Dover, et al.
Journal of Drugs in Dermatology : JDD
|
June 23, 2009
The efficacy and safety of a new U.S. Botulinum toxin type A in the retreatment of glabellar lines following open-label treatment
Mark G Rubin, Jeffrey Dover, Richard G Glogau, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 18) with videos related to
Sort By:
Page
of 2
Journal of Drugs in Dermatology : JDD
|
November 7, 2022
#Laser Surgery: How Lasers are Portrayed on Instagram
Jessica Labadie, Supriya Immaneni, Jeffrey Dover
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
January 5, 2022
Surgical Dermatology and Private Equity: A Review of the Literature and Discussion
Alexander L Fogel, Sara Hogan, Jeffrey Dover
Skin Therapy Letter
|
July 13, 2023
DaxibotulinumtoxinA-lanm (Daxxify™): A Comprehensive Overview
Nicole Salame, Ariel E Eber, Jeffrey Dover
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
July 8, 2026
Clinical Risk and Regulatory Oversight for Office-Based Cosmetic Procedures: A State-By-State Analysis
Sara Hogan, Micah Brown, Jamon Thomas, et al.
Journal of the American Academy of Dermatology
|
October 27, 2012
Evaluating facial pores and skin texture after low-energy nonablative fractional 1440-nm laser treatments
Nazanin Saedi, Kathleen Petrell, Kenneth Arndt, et al.
Journal of Cosmetic Dermatology
|
September 18, 2021
The impact of COVD-19 on North American dermatology practices
Misha Zarbafian, Danny Guo, Jeffrey Dover, et al.
Aesthetic Surgery Journal
|
December 1, 2009
An analysis of safety data from five phase III clinical trials on the use of botulinum neurotoxin type A-ABO for the treatment of glabellar lines
Mark Rubin, Jeffrey Dover, Corey Maas, et al.
Archives of Dermatology
|
April 21, 2010
Blinded, randomized, quantitative grading comparison of minimally invasive, fractional radiofrequency and surgical face-lift to treat skin laxity
Macrene Alexiades-Armenakas, David Rosenberg, Bradley Renton, et al.
Clinics in Dermatology
|
January 4, 2020
The malleability of beauty: perceptual adaptation
Mayra B C Maymone, Melissa Laughter, Jeffrey Dover, et al.
Journal of Drugs in Dermatology : JDD
|
June 23, 2009
The efficacy and safety of a new U.S. Botulinum toxin type A in the retreatment of glabellar lines following open-label treatment
Mark G Rubin, Jeffrey Dover, Richard G Glogau, et al.
Page
of 2